TESTOSTERONE UNDECYLATE
Priapism
Johns Hopkins UniversitySmall moleculeEarly Phase 1Dormant
C
39/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 24/ 100
- Competitive Position
- 95/ 100
Competitive context
2 Active assets in the Priapism cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Hydroxyurea Vanderbilt University Medical Center | Phase 2 | B |
Crizanlizumab Novartis Pharmaceuticals | Phase 2 | B |
Tadalafil Vanderbilt University Medical Center | Phase 2 | B |
Sildenafil Johns Hopkins University | Phase 2 | B |
Same molecule, other indications
TESTOSTERONE UNDECYLATE is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →